Erratum: Ursolic acid and luteolin-7-glucoside improve lipid profiles and increase liver glycogen content through glycogen synthase kinase-3 (Phytotherapy Research (2010) 24, Supplement 2, DOI: 10.1002/ptr.3118);Ursolic acid and luteolin-7-glucoside improve lipid profiles and increase liver glycogen content through glycogen synthase kinase-3

Phytotherapy Research

Volumn 24, Issue SUPPL. 2, 2010, Pages

  Azevedo, Marisa F ^a   Camsari, Çagri ^a,b   Sá, Carla M ^a   Lima, Cristovao F ^a   Fernandes Ferreira, Manuel ^a   Pereira Wilson, Cristina ^a  

^a UNIVERSITY OF MINHO   (Portugal)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Functional foods; Lamiaceae species; Lipid profile; Liver glycogen; Luteolin 7 glucoside; Ursolic acid

Indexed keywords

BETA ACTIN; GLUCOSE; GLYCOGEN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; LUTEOLIN 7 GLUCOSIDE; URSOLIC ACID; CHOLESTEROL; GLUCOSE BLOOD LEVEL; GLUCOSIDE; GLYCOGEN LIVER LEVEL; LUTEOLIN; LUTEOLIN-7-GLUCOSIDE; TRITERPENE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CHOLECYSTOKININ BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME PHOSPHORYLATION; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; HIGH RISK POPULATION; IN VIVO STUDY; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; RAT; ANIMAL; BLOOD; DRUG EFFECTS; LIVER; METABOLISM; PHOSPHORYLATION; WISTAR RAT;

LAMIACEAE; RATTUS;

ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; GLUCOSIDES; GLYCOGEN SYNTHASE KINASE 3; LIPIDS; LIVER; LIVER GLYCOGEN; LUTEOLIN; PHOSPHORYLATION; RATS; RATS, WISTAR; TRITERPENES;

EID: 77953884960     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3118     Document Type: Erratum

References (31)

1. Alarcon-Aguilar FJ, Roman-Ramos R, Flores-Saenz JL, Aguirre-Garcia F. 2002. Investigation on the hypoglycaemic effects of extracts of four Mexican medicinal plants in normal and alloxandiabetic mice. Phytother Res 16: 383-386. (Pubitemid 34700279)
2. Baricevic D, Bartol T. 2000. The biological/pharmacological activity of the Salvia genus. In SAGE - The Genus Salvia, Kintzios SE (ed.). Harwood Academic Publishers: Amsterdam; 143-184.
3. Cazarolli LH, Folador P, Pizzolatti MG, Mena Barreto Silva FR. 2009. Signaling pathway of kaempferol-3-neohesperidoside in glycogen synthesis in rat soleus muscle. Biochimie 91: 843-849.
4. Ciaraldi TP, Oh DK, Christiansen L, Nikoulina SE, Kong AP, Baxi S, Mudaliar S, Henry RR. 2006. Tissue-specific expression and regulation of GSK-3 in human skeletal muscle and adipose tissue. Am J Physiol Endocrinol Metab 291: E891-E898.
5. Costacou T, Mayer-Davis EJ. 2003. Nutrition and prevention of type 2 diabetes. Annu Rev Nutr 23: 147-170.
6. Eidi M, Eidi A, Zamanizadeh H. 2005. Effect of Salvia officinalis L. leaves on serum glucose and insulin in healthy and streptozotocin-induced diabetic rats. J Ethnopharmacol 100: 310-313. (Pubitemid 41206627)
7. Goodyear LJ, Giorgino F, Sherman LA, Carey J, Smith RJ, Dohm GL. 1995. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 95: 2195-2204.
8. Hertog MG, Hollman PC, Katan MB, Kromhout D. 1993. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr Cancer 20: 21-29. (Pubitemid 23225364)
9. Janicsak G, Veres K, Kakasy AZ, Mathe I. 2006. Study of the oleanolic and ursolic acid contents of some species of the Lamiaceae. Biochem Syst Ecol 34: 392-396.
10. Jayaprakasam B, Olson LK, Schutzki RE, Tai MH, Nair MG. 2006. Amelioration of obesity and glucose intolerance in high-fat-fed C57BL/6 mice by anthocyanins and ursolic acid in cornelian cherry (Cornus mas). J Agric Food Chem 54: 243-248. (Pubitemid 43119946)
11. Jung SH, Ha YJ, Shim EK, Choi SY, Jin JL, Yun-Choi HS, Lee JR. 2007. Insulin-mimetic and insulin-sensitizing activities of a pentacyclic triterpenoid insulin receptor activator. Biochem J 403: 243-250.
12. Kastelein JJ. 2005. Modifying plasma low-density lipoprotein and high-density lipoprotein cholesterol: what combinations are available in the future? Am J Cardiol 96: 20K-27K.
13. Keppler D, Decker K. 1974. Glycogen: determination with amyloglucosidase. In Methods of Enzymatic Analysis, Bergmeyer HU (ed). Weinheim: Verlage Chemie; 1127-1131.
14. Kersten S. 2008. Peroxisome proliferators activated receptors and lipoprotein metabolism. PPAR Res 2008: 132960. (Pubitemid 350243189)
15. Klover PJ, Mooney RA. 2004. Hepatocytes: critical for glucose homeostasis. Int J Biochem 36: 753-758.
16. Lee J, Kim MS. 2007. The role of GSK3 in glucose homeostasis and the development of insulin resistance. Diabetes Res Clin Pract 77: S49-S57. (Pubitemid 47212553)
17. Levetan C. 2007. Oral antidiabetic agents in type 2 diabetes. Curr Med Res Opin 23: 945-952. (Pubitemid 46631497)
18. Lima CF, Andrade PB, Seabra RM, Fernandes-Ferreira M, Pereira-Wilson C. 2005. The drinking of a Salvia officinalis infusion improves liver antioxidant status in mice and rats. J Ethnopharmacol 97: 383-389. (Pubitemid 40222043)
19. Lima CF, Azevedo MF, Araujo R, Fernandes-Ferreira M, Pereira-Wilson C. 2006a. Metformin-like effect of Salvia officinalis (common sage): is it useful in diabetes prevention? Br J Nutr 96: 326-333. (Pubitemid 46470100)
20. Lima CF, Fernandes-Ferreira M, Pereira-Wilson C. 2006b. Phenolic compounds protect HepG2 cells from oxidative damage: relevance of glutathione levels. Life Sci 79: 2056-2068. (Pubitemid 44528584)
21. Lin CL, Lin JK. 2008. Epigallocatechin gallate (EGCG) attenuates high glucose-induced insulin signalling blockade in human hepG2 hepatoma cells. Mol Nutr Food Res 52: 930-939.
22. Mooradian AD. 2009. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab 5:150-159.
23. Nomura M, Takahashi T, Nagata N, Tsutsumi K, Kobayashi S, Akiba T, Yokogawa K, Moritani S, Myiamoto K. 2008. Inhibitory mechanisms of flavonoide on insulin-stimulated glucose uptake in MC3T3-G2/PA6 adipose cells. Biol Pharm Bull 31: 1403-1409. (Pubitemid 351930656)
24. Perfumi M, Arnold N, Tacconi R. 1991. Hypoglycemic activity of Salvia fruticosa Mill. from Cyprus. J Ethnopharmacol 34: 135-140.
25. Pratipanawatr W, Pratipanawatr T, Cusi K, Berria R, Adams JM, Jenkinson CP, Maezono K, DeFronzo RA, Mandarino LJ. 2001. Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation. Diabetes 50: 2572-2578. (Pubitemid 33642776)
26. Postic C, Dentin R, Girard J. 2004. Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes Metab 30: 398-408. (Pubitemid 39648006)
27. Ramos AA, Lima CF, Pereira ML, Fernandes-Ferreira M, Pereira-Wilson C. 2008. Antigenotoxic effects of quercetin, rutin and ursolic acid on HepG2 cells: Evaluation by the comet assay. Toxicol Lett 177: 66-73.
28. Sá CM, Ramos AA, Azevedo MF, Lima CF, Fernandes-Ferreira M, Pereira-Wilson C. 2009. Sage tea drinking improves lipid profile and antioxidant defences in humans. Int J Mol Sci 10: 3937-3950.
29. Waltner-Law ME, Wang XL, Law BK, Hall RK, Nawano M, Granner DK. 2002. Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J Biol Chem 277: 34933-34940.
30. Xavier CP, Lima CF, Preto A, Seruca R, Fernandes-Ferreira M, Pereira-Wilson C. 2009. Luteolin, quercetin and ursolic acid are potent inhibitors of proliferation and inducers of apoptosis in both KRAS and BRAF mutated human colorectal cancer cells. Cancer Lett 281: 162-170.
31. Yin MC, Chan KC. 2007. Nonenzymatic antioxidative and antiglycative effects of oleanolic acid and ursolic acid. J Agric Food Chem 55: 7177-7181. (Pubitemid 47338963)